Management of Insomnia in an Elderly Male with Glaucoma
Cognitive behavioral therapy for insomnia (CBT-I) should be the first-line treatment for this elderly male patient, regardless of his glaucoma status, as it provides superior long-term outcomes without the medication-related risks that are particularly concerning in elderly patients with glaucoma. 1, 2
Initial Assessment
Before initiating treatment, evaluate the following specific factors:
- Medication review: Identify prescription and non-prescription drugs that may cause or worsen insomnia, including β-blockers (commonly used for glaucoma), bronchodilators, corticosteroids, decongestants, diuretics, SSRIs, and SNRIs 2
- Comorbid conditions: Determine whether insomnia is primary or secondary to other medical or psychiatric conditions, as older adults typically have multiple contributing factors 2
- Sleep-impairing behaviors: Assess for daytime napping, excessive time in bed, insufficient physical activity, evening alcohol consumption, and late heavy meals 2
First-Line Treatment: Cognitive Behavioral Therapy for Insomnia
CBT-I must be implemented as initial therapy before considering any pharmacological options, with effects sustained for up to 2 years in older adults 1, 2. This approach is particularly critical in elderly patients with glaucoma because many sleep medications carry risks that are amplified in this population.
Core Components to Implement
Cognitive Restructuring (essential first component):
- Identify and challenge dysfunctional beliefs such as "I cannot sleep without medication," "I have a chemical imbalance," or "My life will be ruined if I don't sleep" 3
- These misconceptions fuel performance anxiety and must be addressed directly 3
Sleep Restriction/Compression Therapy:
- Limit time in bed to actual sleep time based on a 1-2 week sleep diary 2, 3
- Use sleep compression (gradual reduction) rather than immediate restriction, as it is better tolerated in elderly patients 2, 3
- Increase time in bed by 15-20 minutes every 5-7 days if sleep efficiency exceeds 85-90% 3
Stimulus Control:
- Use the bedroom only for sleep and sexual activity 2, 3
- Leave the bedroom if unable to fall asleep within 20 minutes and return only when sleepy 2, 3
- Maintain consistent wake-up times regardless of sleep duration 3
- Go to bed only when sleepy 3
Relaxation Techniques:
- Teach progressive muscle relaxation, guided imagery, or diaphragmatic breathing to reduce arousal 2, 3
- These techniques help achieve a calm state conducive to sleep onset 2
Sleep Hygiene Education (adjunctive only):
- Address environmental factors including comfortable bedroom temperature, noise reduction, and light control 2
- This is most effective when combined with other modalities rather than as standalone treatment 2
Delivery Format
In-person therapist-led CBT-I provides the greatest benefit, though telephone-based, web-based modules, or self-help books are also effective alternatives 1, 4
Second-Line Treatment: Pharmacological Intervention
Pharmacotherapy should only be considered after CBT-I has been unsuccessful, using shared decision-making that discusses benefits, harms, and costs of short-term medication use 1, 2.
Critical Considerations for Glaucoma Patients
Avoid anticholinergic medications entirely in patients with glaucoma, as they can precipitate acute angle-closure glaucoma. This specifically excludes:
- Over-the-counter antihistamines (diphenhydramine) 2
- Tricyclic antidepressants at higher doses
- First-generation antihistamines
Recommended Pharmacological Sequence
For sleep onset insomnia:
- First choice: Ramelteon at the lowest available dose (no anticholinergic effects, safe in glaucoma) 2, 3
- Alternative: Short-acting Z-drugs (zaleplon, low-dose zolpidem) 3
For sleep maintenance insomnia:
For both onset and maintenance:
- Eszopiclone or extended-release zolpidem at the lowest available dose 2
Dosing Principles
- Always start with the lowest available dose in elderly patients due to reduced drug clearance and increased sensitivity to peak effects 2, 3
- Follow patients every few weeks initially to assess effectiveness and side effects 2
- Employ the lowest effective maintenance dosage and taper when conditions allow 2
Medications to Avoid in This Population
Absolutely contraindicated or strongly discouraged:
- Benzodiazepines: Higher risk of falls, cognitive impairment, dependence, and paradoxical behavioral disinhibition in elderly 2, 3
- Antihistamines (diphenhydramine): Anticholinergic effects dangerous in glaucoma, unfavorable risk-benefit profile 2
- Sedating antidepressants (trazodone, amitriptyline, mirtazapine): Should only be used when comorbid depression/anxiety exists, as there is no systematic evidence for effectiveness in primary insomnia 2
- Antipsychotics and anticonvulsants: Unfavorable risk-benefit profiles in elderly for primary insomnia 2
Monitoring and Follow-Up
- Collect sleep diary data before and during treatment 3
- Clinical reevaluation every few weeks until stabilization, then every 6 months 3
- Regular reassessment for treatment effectiveness and potential adverse effects 2
- Monitor for medication side effects, which may be more pronounced in elderly 2
Common Pitfalls to Avoid
Do not prescribe medications as first-line treatment, as this reinforces beliefs about having a "chemical problem" and increases resistance to future behavioral interventions 3. This is particularly problematic in elderly patients who may develop dependence or experience adverse effects.
Do not rely on sleep hygiene education alone, as it is usually insufficient for treating chronic insomnia and should be combined with other CBT-I components 2, 4.
Do not use long-term pharmacotherapy without concurrent CBT-I trials whenever possible 2.